Relypsa, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (25)

Latest Posts

About This Stock More About This Stock
7 Stocks To Buy In The Market’s 3 Hottest Sectors
Article By: Bret Jensen
Saturday, July 30, 2016 1:58 PM EDT
Invest in the momentum of these seven stocks spanning three different sectors that all have strong economic tailwinds lifting their revenues, profits, and stock prices higher.
In this article: LVS, PGNX, AAPL, QCOM, PETX, LGIH, TMHC Also: TOL, RLYP
Read
4 Likely Biotech Takeover Targets To Buy
Article By: Bret Jensen
Saturday, July 23, 2016 4:53 PM EDT
After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist.
In this article: ACAD, ARDX, SGYP Also: SNY, MDVN, PGNX, RLYP, AZN, BIIB, ZSPH, AGN, VRX
Read
Biotechs Get Turbo A Boost From Biogen
Article By: Rod Raynovich
Thursday, July 21, 2016 5:12 PM EDT
Risk is on for biotech. Biotech stocks should be higher by year-end. Earnings on major large caps need to support rally.
In this article: IBB, BIIB Also: INCY, REGN, SGEN, CELG, VRTX, XBI, RLYP
Read
Morning Call For May 5, 2016
Article By: Jim Van Meerten
Thursday, May 5, 2016 7:59 AM EDT
Jun E-mini S&Ps (ESM16 +0.28%) are up +0.28% and European stocks are up +0.28% as a +2.83% jump in crude oil (CLM16 +2.74%) lifts energy producing stocks.
In this article: CTL, MCK, MET, PRU, WTW, TSLA, WFM, TRIP, KHC, RLYP
Read
3 Undervalued Biotech Stocks With Upcoming Catalysts - April 16, 2016
Article By: Bret Jensen
Saturday, April 16, 2016 12:11 PM EDT
Bret Jensen recommends buying these three cheap biotech stocks because they might not be so cheap once summer is over.
In this article: DVAX, MRNS, RARE Also: AGN, PFE, MDVN, EGRX, RLYP
Read

Latest Tweets for $RLYP

No tweets yet!

PARTNER HEADLINES